FDA may limit anemia drug use for kidney disease - The Associated Press PDF Print
The Associated PressPre-dialysis kidney patients contributed 30 percent of Aranesp's revenue last year, estimates Robyn Karnauskas, an analyst at Deutsche Bank.

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.